ResMed Inc. (LON:0KW4)

ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of GBP 27.43 billion. The enterprise value is 27.01 billion.

Market Cap	27.43B
Enterprise Value	27.01B

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Nov 13, 2025

Share Statistics

Current Share Class	145.68M
Shares Outstanding	n/a
Shares Change (YoY)	-0.43%
Shares Change (QoQ)	-0.36%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	71.86%
Float	144.75M

Valuation Ratios

The trailing PE ratio is 24.85 and the forward PE ratio is 22.26.

PE Ratio	24.85
Forward PE	22.26
PS Ratio	6.84
PB Ratio	5.84
P/TBV Ratio	12.97
P/FCF Ratio	20.61
P/OCF Ratio	19.28
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.92, with an EV/FCF ratio of 20.29.

EV / Earnings	24.47
EV / Sales	6.87
EV / EBITDA	17.92
EV / EBIT	20.03
EV / FCF	20.29

Financial Position

The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.13.

Current Ratio	3.06
Quick Ratio	1.97
Debt / Equity	0.13
Debt / EBITDA	0.41
Debt / FCF	0.47
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 25.68% and return on invested capital (ROIC) is 26.60%.

Return on Equity (ROE)	25.68%
Return on Assets (ROA)	14.75%
Return on Invested Capital (ROIC)	26.60%
Return on Capital Employed (ROCE)	25.44%
Weighted Average Cost of Capital (WACC)	8.86%
Revenue Per Employee	378,378
Profits Per Employee	104,151
Employee Count	10,600
Asset Turnover	0.69
Inventory Turnover	2.15

Taxes

In the past 12 months, ResMed has paid 247.28 million in taxes.

Income Tax	247.28M
Effective Tax Rate	18.30%

Stock Price Statistics

The stock price has decreased by -0.17% in the last 52 weeks. The beta is 0.88, so ResMed's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	-0.17%
50-Day Moving Average	250.75
200-Day Moving Average	257.77
Relative Strength Index (RSI)	48.55
Average Volume (20 Days)	216

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	11.08

Income Statement

In the last 12 months, ResMed had revenue of GBP 4.01 billion and earned 1.10 billion in profits. Earnings per share was 7.51.

Revenue	4.01B
Gross Profit	2.47B
Operating Income	1.37B
Pretax Income	1.35B
Net Income	1.10B
EBITDA	1.50B
EBIT	1.37B
Earnings Per Share (EPS)	7.51

Balance Sheet

The company has 1.05 billion in cash and 629.86 million in debt, with a net cash position of 423.03 million.

Cash & Cash Equivalents	1.05B
Total Debt	629.86M
Net Cash	423.03M
Net Cash Per Share	n/a
Equity (Book Value)	4.70B
Book Value Per Share	32.24
Working Capital	1.91B

Cash Flow

In the last 12 months, operating cash flow was 1.42 billion and capital expenditures -91.30 million, giving a free cash flow of 1.33 billion.

Operating Cash Flow	1.42B
Capital Expenditures	-91.30M
Free Cash Flow	1.33B
FCF Per Share	n/a

Margins

Gross margin is 61.47%, with operating and profit margins of 34.19% and 27.53%.

Gross Margin	61.47%
Operating Margin	34.19%
Pretax Margin	33.69%
Profit Margin	27.53%
EBITDA Margin	37.51%
EBIT Margin	34.19%
FCF Margin	33.19%

Dividends & Yields

This stock pays an annual dividend of 1.72, which amounts to a dividend yield of 0.68%.

Dividend Per Share	1.72
Dividend Yield	0.68%
Dividend Growth (YoY)	8.47%
Years of Dividend Growth	4
Payout Ratio	22.88%
Buyback Yield	0.43%
Shareholder Yield	1.11%
Earnings Yield	4.02%
FCF Yield	4.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ResMed has an Altman Z-Score of 12.89 and a Piotroski F-Score of 6.

Altman Z-Score	12.89
Piotroski F-Score	6